Liang Fang Selected Research

sodium sulfate (sodium bisulfate)

1/2022	Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.
1/2016	Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Fang Research Topics

Disease

52	Neoplasms (Cancer) 01/2024 - 01/2005
11	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2010
10	Inflammation (Inflammations) 12/2023 - 01/2016
9	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 12/2012
8	Pain (Aches) 12/2023 - 05/2008
6	Carcinogenesis 11/2022 - 02/2016
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 08/2015
6	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2014
5	Infections 03/2023 - 11/2005
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2008
4	Osteonecrosis (Kienbock's Disease) 02/2024 - 12/2019
4	Stroke (Strokes) 11/2022 - 01/2012
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2005
4	Experimental Arthritis 10/2018 - 07/2013
4	Squamous Cell Carcinoma of Head and Neck 03/2018 - 09/2008
4	Vomiting 09/2016 - 11/2012
4	Nausea 09/2016 - 11/2012
3	Bipolar Disorder (Manic Depressive Psychosis) 02/2024 - 01/2014
3	Colonic Neoplasms (Colon Cancer) 01/2024 - 02/2016
3	COVID-19 03/2023 - 03/2021
3	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 01/2018
3	Papillary Thyroid Cancer 01/2021 - 03/2017
3	Hypoxia (Hypoxemia) 01/2017 - 10/2006
3	Hypertension (High Blood Pressure) 12/2010 - 05/2006
3	Leukemia 12/2008 - 02/2007
2	Mood Disorders (Mood Disorder) 02/2024 - 01/2014
2	Wounds and Injuries (Trauma) 12/2023 - 06/2017
2	Cardiomyopathies (Cardiomyopathy) 10/2023 - 05/2023
2	Osteoarthritis 08/2023 - 01/2019
2	Bone Resorption 07/2023 - 01/2011
2	Lung Neoplasms (Lung Cancer) 04/2023 - 12/2019
2	Ischemic Stroke 01/2023 - 07/2020
2	Lymphoma (Lymphomas) 07/2022 - 01/2021
2	Colitis 01/2022 - 01/2016
2	Obesity 01/2022 - 06/2019
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 11/2019
2	Necrosis 10/2021 - 06/2017
2	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 01/2019
2	Rheumatoid Arthritis 01/2021 - 07/2013
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2015
2	Osteoporosis 01/2021 - 07/2020
2	Dysbiosis 01/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2011
2	Bone Fractures (Bone Fracture) 10/2020 - 06/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 06/2017

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2006
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
9	CateninsIBA 02/2024 - 07/2013
7	Therapeutic UsesIBA 03/2023 - 04/2011
7	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2011
7	Analgesics (Analgesic Drugs)IBA 01/2022 - 07/2013
5	Acetic Acid (Vinegar)FDA LinkGeneric 01/2021 - 07/2013
5	LigandsIBA 11/2020 - 06/2006
5	Ado-Trastuzumab EmtansineIBA 05/2014 - 09/2012
4	CytokinesIBA 04/2024 - 01/2019
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2013
4	EnzymesIBA 10/2023 - 05/2014
4	Messenger RNA (mRNA)IBA 07/2022 - 05/2014
4	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 02/2011
3	CollagenIBA 04/2024 - 05/2022
3	SteroidsIBA 01/2023 - 12/2019
3	Peptide Initiation Factors (Initiation Factor)IBA 03/2018 - 01/2017
3	pertuzumabIBA 05/2014 - 09/2012
3	AntigensIBA 03/2013 - 01/2005
3	Bevacizumab (Avastin)FDA Link 06/2011 - 01/2011
2	MelatoninIBA 02/2024 - 01/2021
2	Ethylene Glycol (Monoethylene Glycol)IBA 02/2024 - 03/2012
2	GlucocorticoidsIBA 02/2024 - 01/2023
2	Small Cytoplasmic RNAIBA 01/2024 - 01/2021
2	Phenobarbital (Luminal)FDA Link 11/2023 - 01/2020
2	LipopolysaccharidesIBA 05/2023 - 11/2021
2	ChemokinesIBA 01/2023 - 12/2013
2	Fatty Acid-Binding ProteinsIBA 01/2023 - 11/2022
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
2	Lipopolysaccharide ReceptorsIBA 11/2022 - 11/2016
2	6-methyladenineIBA 07/2022 - 06/2021
2	MicellesIBA 03/2022 - 10/2016
2	Collagen Type IXIBA 03/2022 - 01/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 01/2016
2	C-Reactive ProteinIBA 01/2022 - 11/2016
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 04/2015
2	Dextrans (Dextran)FDA Link 01/2022 - 01/2016
2	Complement System Proteins (Complement)IBA 04/2021 - 01/2018
2	Neuroprotective AgentsIBA 03/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2010
2	cupric sulfide (CuS)IBA 01/2020 - 08/2015
2	EpitopesIBA 01/2020 - 11/2005
2	Peptides (Polypeptides)IBA 01/2020 - 11/2005
2	N-acetyltalosaminuronic acid (NAT)IBA 12/2019 - 12/2010
2	Polysaccharides (Glycans)IBA 11/2019 - 09/2009

Therapy/Procedure

18	Therapeutics 05/2023 - 09/2010
14	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
6	Transdermal Patch 01/2021 - 12/2009
4	Radiotherapy 01/2022 - 03/2008
3	Analgesia 12/2023 - 07/2020
3	Length of Stay 04/2023 - 03/2017
3	Deep Brain Stimulation 03/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2021 - 02/2007